New Product Approvals

The Food and Drug Administration limited the use of the Covid-19 vaccine from Johnson & Johnson after reviewing the risk of life-threatening blood clots.The agency said Thursday that the J&J shot’s…

The Food and Drug Administration rejected two proposed new cancer drugs that were developed in China, underscoring a tougher U.S. regulatory stance toward such drugs.Hong Kong-based Hutchmed Ltd. said Monday…

TOKYO—Drugmaker Shionogi & Co. said it plans to seek approval this month to sell its Covid-19 treatment pill in Japan after the company found that in human trials the pill had strong virus-fighting ability compared with Pfizer Inc.’s…

SINGAPORE—China has notified some companies of new rules that require the country’s biggest internet firms to seek approval for investment deals, a mechanism that is likely to curb domestic technology giants from…

U.S. health regulators cleared use of a Covid-19 booster from Pfizer Inc. PFE -4.06% and BioNTech SE BNTX -10.07% in adolescents 12 to…

Roche Holding AG RHHBY -0.59% is adding an experimental drug for a blinding eye condition in a deal aimed at helping the company move further into cell-based therapies.Roche’s Genentech…

Biogen Inc. BIIB 0.81% is slashing in half the price of its controversial new Alzheimer’s disease treatment, Aduhelm, in a bid to revive a product launch that has…

The new business, which isn’t yet named, will be led by current Discovery Chief Executive David Zaslav. The companies said Jason Kilar will retain his title as CEO of AT&T’s…

AstraZeneca PLC AZN 0.62% could skip asking the Food and Drug Administration for emergency-use authorization for its Covid-19 vaccine, according to people familiar with the matter—and…

AstraZeneca AZN -1.36% PLC executives have struggled to pull together the full data necessary to apply for U.S. approval of its Covid-19 shot, according to people familiar with the…